Breakthrough T1D Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications
Two of the world’s most respected and trusted health publications have tapped Breakthrough T1D to serve as an expert voice…
Testimony of Dr. Aaron Kowalski, Chief Mission Officer, Breakthrough T1D House Energy & Commerce Committee Oversight And Investigations Subcommittee
‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone,…
Insulin pumps, CGMs and more: is T1D Tech right for you?
Hear from six people living with T1D about their #T1DTech, the fears they had before using their various devices, and…
European Commission Has Approved Forxiga for Adults with Type 1 Diabetes
It’s official: The European Commission has approved Forxiga® (dapagliflozin and marketed in the United States as Farxiga®) for adults with…
